Moderna
MRNA
#1595
Rank
S$14.14 B
Marketcap
$36.57
Share price
-4.04%
Change (1 day)
-74.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -$12.56

According to Moderna 's latest financial reports the company's current EPS (TTM) is -$12.29. In 2022 the company made an earnings per share (EPS) of $28.39 a decrease over its 2021 EPS that were of $40.71.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.56-144.22%
2022$28.39-30.25%
2021$40.71-1660.82%
2020-$2.6125.16%
2019-$2.0837.04%
2018-$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.27-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.07-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.53-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.03-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.29-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.94-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA